Nektar Therapeutics
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
/ 
Frequently asked questions
To buy Nektar Therapeutics stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Nektar Therapeutics by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Nektar Therapeutics is NKTR:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Nektar Therapeutics has its primary listing on NASDAQ. You can trade Nektar Therapeutics with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Nektar Therapeutics is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Nektar Therapeutics as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Nektar Therapeutics.